Leukoplakia and Erythroplakia (Oral Premalignant Lesions)
Clinical descriptors of oral white (leukoplakia) and red (erythroplakia) patches that cannot be scraped off — premalignant; biopsy any persistent lesion.
Also known as: leukoplakia, erythroplakia, oral premalignant lesion, oral potentially malignant disorder, OPMD
Overview
Leukoplakia is a white plaque of the oral mucosa that cannot be scraped off and cannot be classified clinically or pathologically as any other disease. Erythroplakia is a red, velvety mucosal patch that similarly cannot be otherwise classified. Both are clinical descriptors; the underlying histology may range from hyperkeratosis to dysplasia to invasive carcinoma.
Epidemiology
Leukoplakia: prevalence approximately 1-5% in adults; more common in middle-aged to older men. Malignant transformation rate is 1-5% over 5 years for homogeneous leukoplakia; substantially higher (up to 30%) for nonhomogeneous, proliferative verrucous, or dysplastic forms. Erythroplakia: much less common (about 0.02-0.1%) but with malignant transformation rates of 14-50%; greater than 90% of biopsies show severe dysplasia or carcinoma.
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Leukoplakia and Erythroplakia (Oral Premalignant Lesions) outline — plus all 514 diagnoses, 5,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Risk factors
- Tobacco use in any form (cigarettes, cigars, pipe, smokeless tobacco)
- Heavy alcohol use
- Betel nut/areca chewing
- Human papillomavirus infection (especially high-risk types)
- Chronic mucosal trauma (rough teeth, ill-fitting dentures)
- Candida infection (associated with nonhomogeneous lesions)
- Immunosuppression
Pathophysiology
Field cancerization — chronic carcinogen exposure produces multiple foci of genetically altered mucosa. Leukoplakia represents hyperkeratosis with variable dysplasia; erythroplakia reflects mucosal atrophy that exposes the underlying capillaries, often with severe dysplasia or carcinoma in situ. The risk of malignant transformation increases with size, nonhomogeneous appearance, high-risk subsite, presence of dysplasia, and continued carcinogen exposure.
Clinical presentation
Symptoms
- Often asymptomatic; lesions are discovered on routine dental or medical exam
- Patients may notice a 'rough patch,' burning, or sensitivity to spicy foods
- Bleeding or ulceration is a worrisome sign for transformation
Signs / physical exam
- Leukoplakia: white plaque that cannot be removed with gauze; may be homogeneous (smooth, thin) or nonhomogeneous (nodular, verrucous, mixed red-white)
- Proliferative verrucous leukoplakia: multifocal, persistent, slowly enlarging, highly transformation-prone
- Erythroplakia: red, velvety, well-demarcated mucosal patch, often atrophic, usually on the floor of mouth, lateral tongue, soft palate, or retromolar trigone
- Erythroleukoplakia: mixed red and white lesion; higher dysplasia/carcinoma risk than pure leukoplakia
- Induration, ulceration, or rapid change suggests malignant transformation
Classic findings
Painless white plaque (leukoplakia) or red velvety patch (erythroplakia) in a smoker, located on the lateral tongue or floor of mouth, that cannot be scraped off and persists beyond 2-3 weeks.
Differential diagnosis
- Frictional hyperkeratosis (e.g., linea alba) — Bilateral white line along occlusal plane in buccal mucosa; reproducible with cheek-biting habit; benign
- Oral lichen planus — Bilateral lace-like white striae (Wickham), often erosive; chronic and symmetrical; biopsy if atypical
- Pseudomembranous candidiasis (thrush) — White plaques that WIPE OFF leaving erythematous mucosa; responds to antifungals
- Leukoedema — Generalized milky-white opalescent buccal mucosa that disappears with stretching; benign variant; common in dark-skinned individuals
- White sponge nevus — Hereditary, present since childhood, generalized white folded mucosa; benign
- Hairy leukoplakia (EBV) — Corrugated white plaque on lateral tongue in immunocompromised (HIV); does not wipe off; non-premalignant
- Mucosal erythema from chronic inflammation — Diffuse and reactive; resolves with elimination of irritant
Diagnostic workup
Diagnostic criteria
Clinical descriptors confirmed by exclusion of other diagnoses. Definitive risk stratification is by histopathology: hyperkeratosis without dysplasia, mild/moderate/severe dysplasia, carcinoma in situ, or invasive SCC.
Labs
- Generally none required at the initial visit
- HIV testing if hairy leukoplakia or risk factors are present
Imaging
- Incisional biopsy of any persistent leukoplakia or erythroplakia — gold standard; from the most suspicious area (induration, ulceration, red component)
- Multiple biopsies for large or nonhomogeneous lesions
- Adjuncts such as toluidine blue staining, autofluorescence (VELscope), or brush biopsy may help select biopsy site but DO NOT replace tissue diagnosis
- Imaging (CT/MRI) only if invasive carcinoma is suspected or for staging
Diagnostic algorithm
| Feature | Homogeneous leukoplakia | Nonhomogeneous leukoplakia | Erythroplakia |
|---|---|---|---|
| Color | White, uniform | White with red or nodular areas | Red, velvety |
| Surface | Flat, smooth, thin | Verrucous, nodular, mixed | Atrophic, well-demarcated |
| Wipes off | No | No | No |
| Dysplasia at biopsy | 5-25% | 20-50% | Greater than 80-90% |
| Malignant transformation | 1-5% over 5 years | 10-30% over 5 years | 14-50% (highest) |
| Management | Risk factor control + biopsy + surveillance; excise if dysplasia | Biopsy + excise; surveillance | Biopsy + complete excision |
Treatment
First-line
- Eliminate risk factors — complete tobacco cessation (including smokeless), alcohol reduction, removal of mechanical irritants (smoothing of sharp teeth, refit dentures), treatment of candida if present
- Surgical excision of all erythroplakia and of any lesion with moderate or severe dysplasia or carcinoma in situ
- Excision or close surveillance of homogeneous leukoplakia without dysplasia, depending on size, site, and patient risk factors
Second-line / adjunct
- Carbon dioxide laser ablation or cryotherapy as alternatives to scalpel excision for accessible lesions
- Photodynamic therapy in selected centers
- Topical agents (retinoids, bleomycin) have been studied but are not standard of care
- Lifelong clinical surveillance — every 3-6 months for moderate-risk lesions, every 6-12 months for low-risk lesions
- Re-biopsy any clinical change (color, induration, ulceration, growth)
Complications
- Malignant transformation to invasive squamous cell carcinoma
- Recurrence after excision (up to 30%, higher for proliferative verrucous leukoplakia)
- Functional impairment after extensive excision
- Field cancerization with metachronous lesions and second primaries
PANCE pearls
- Leukoplakia and erythroplakia are clinical diagnoses of EXCLUSION; rule out lichen planus, candidiasis, and other named entities.
- Erythroplakia and erythroleukoplakia have a far higher dysplasia and cancer rate than homogeneous leukoplakia — biopsy and excise.
- If a 'leukoplakia' wipes off, it is candidiasis until proven otherwise.
- Proliferative verrucous leukoplakia is the most aggressive variant — multifocal, persistent, transformation rates approaching 70%.
- Even after complete excision, lifelong surveillance is required because of field cancerization.
References
- WHO — WHO Classification of Head and Neck Tumours, 4th/5th edition — Oral potentially malignant disorders
- ADA — American Dental Association evidence-based clinical recommendations on the diagnosis of oral potentially malignant disorders (Lingen et al., JADA 2017)
- NCCN — NCCN Clinical Practice Guidelines: Head and Neck Cancers — screening and premalignant lesions
Practice EENT questions on FirstPassPA
Turn this outline into retention. 5,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Start studying free → Browse all 514 diagnosesEducational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.